Research Paper Volume 16, Issue 7 pp 5866—5886
NXPH4 can be used as a biomarker for pan-cancer and promotes colon cancer progression
Figure 2. Copy number variation and methylation of NXPH4 in pan-cancer. (A) Copy number variation in NXPH4 in pan-cancer. (B) Correlation between copy number variation and mRNA expression level of NXPH4 in pan-cancer. (C) Differential methylation levels of NXPH4 between pan-cancers and corresponding paracancer tissues. (D) Relationship between NXPH4 methylation levels and prognosis in pan-cancers.